Development and Characterization of Monoclonal Antibodies against Nucleoprotein for Diagnosis of Influenza A Virus
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Influenza, which is a highly contagious disease caused by the influenza A virus, continues to be a major health concern worldwide. Although the accurate and early diagnosis of influenza virus infection is important for controlling the spread of this disease and rapidly initiating antiviral therapy, the current influenza diagnostic kits are limited by their low sensitivity. In this study, we developed several new influenza nucleoprotein (NP)-specific monoclonal antibodies (mAbs) and compared their sensitivity and specificity of those with commercially available anti-NP mAbs. Three mAbs, designated M24.11, M34.3, and M34.33, exhibited higher reactivities to recombinant NPs and A/Puerto Rico/8/1934 (H1N1) viral lysates compared with the commercial mAbs, as assessed using enzyme-linked immunosorbent assays. M34.3 and M34.33 showed higher reactivities with A/California/04/09 (pandemic H1N1) and A/ Philippines/2/82 (H3N2) viral lysates than the commercial mAbs. In contrast, M24.11 had marked reactivity with H3N2 but not with pandemic H1N1. Immunofluorescent confocal microscopy showed that the three mAbs effectively detected the presence of influenza virus in lung tissues of mice infected with A/Puerto Rico/8/1934. These results indicate that the newly developed M34.3 and M34.33 mAbs could be useful for the development of influenza diagnostics.
Abstract
Influenza, which is a highly contagious disease caused by the influenza A virus, continues to be a major health concern worldwide. Although the accurate and early diagnosis of influenza virus infection is important for controlling the spread of this disease and rapidly initiating antiviral therapy, the current influenza diagnostic kits are limited by their low sensitivity. In this study, we developed several new influenza nucleoprotein (NP)-specific monoclonal antibodies (mAbs) and compared their sensitivity and specificity of those with commercially available anti-NP mAbs. Three mAbs, designated M24.11, M34.3, and M34.33, exhibited higher reactivities to recombinant NPs and A/Puerto Rico/8/1934 (H1N1) viral lysates compared with the commercial mAbs, as assessed using enzyme-linked immunosorbent assays. M34.3 and M34.33 showed higher reactivities with A/California/04/09 (pandemic H1N1) and A/ Philippines/2/82 (H3N2) viral lysates than the commercial mAbs. In contrast, M24.11 had marked reactivity with H3N2 but not with pandemic H1N1. Immunofluorescent confocal microscopy showed that the three mAbs effectively detected the presence of influenza virus in lung tissues of mice infected with A/Puerto Rico/8/1934. These results indicate that the newly developed M34.3 and M34.33 mAbs could be useful for the development of influenza diagnostics.
참고문헌 (24)
- Webster RG, "Evolution and ecology of influenza A viruses", Microbiol. Rev., 56, pp.152~179 (1992)
- Cox NJ, "Influenza", Lancet, 354, pp.1277~1282 (1999)[DOI]
- Neumann G, "Emergence and pandemic potential of swine-origin H1N1 influenza virus", Nature, 459, pp.931~939 (2009)[DOI]
- Molinari NA, "The annual impact of seasonal influenza in the US: measuring disease burden and costs", Vaccine, 25, pp.5086~5096 (2007)[DOI]
- Vemula SV, "Current approaches for diagnosis of influenza virus infections in humans", Viruses, 8, pp.96~ (2016)[DOI]
- Kumar S, "Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic", Clin. Microbiol. Rev., 25, pp.344~361 (2012)[DOI]
- Uyeki TM, "Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza", Pediatr. Infect. Dis. J., 22, pp.164~177 (2003)
- Falsey AR, "Impact of rapid diagnosis on management of adults hospitalized with influenza", Arch. Intern. Med., 167, pp.354~360 (2007)[DOI]
- Mizuike R, "Development of two types of rapid diagnostic test kits to detect the hemagglutinin or nucleoprotein of the swine-origin pandemic influenza A virus H1N1", Clin. Vaccine Immunol., 18, pp.494~499 (2011)[DOI]
- Yang M, "Development and application of monoclonal antibodies against avian influenza virus nucleoprotein", J. Virol. Methods, 147, pp.265~274 (2008)[DOI]
- Drexler JF, "Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 virus", Emerg. Infect. Dis., 15, pp.1662~1664 (2009)[DOI]
- Uyeki TM, "Low sensitivity of rapid diagnostic test for influenza", Clin. Infect. Dis., 48, pp.e89~e92 (2009)[DOI]
- Linke S, "Generation and characterisation of monoclonal antibodies against influenza virus A, subtype H5N1", J. Virol. Methods, 175, pp.85~94 (2011)[DOI]
- Wang W, "Robust immunity and heterologous protection against influenza in mice elicited by a novel recombinant NP-M2e fusion protein expressed in E. coli", PLoS One, 7, pp.e52488~ (2012)[DOI]
- Yang J, "Poly-gamma-glutamic acid", chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine, 2017, pp.7, 44839~
- Heo CK, "Identification of autoantibody against fatty acid synthase in hepatocellular carcinoma mouse model and its application to diagnosis of HCC", Int. J. Oncol., 36, pp.1453~1459 (2010)
- Shaw ML, "Cellular proteins in influenza virus particles", PLoS Pathog., 4, pp.e1000085~ (2008)[DOI]
- Heyward JT, "The rapid concentration and purification of influenza virus from allantoic fluid", Arch. Virol., 55, pp.107~119 (1977)[DOI]
- Polson A, "Polyethylene glycol purification of influenza virus with respect to aggregation and antigenicity", J. Hyg. (Lond.), 70, pp.255~265 (1972)[DOI]
- Shu LL, "Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990", J. Virol., 67, pp.2723~2729 (1993)
- Reid AH, "Novel origin of the 1918 pandemic influenza virus nucleoprotein gene", J. Virol., 78, pp.12462~12470 (2004)[DOI]
- Babar MM, "Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target", Infect. Genet. Evol., 34, pp.200~210 (2015)[DOI]
- Ye Q, "The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA", Nature, 444, pp.1078~1082 (2006)[DOI]
- Werthen M, "Effect of antibody affinity on the isotherm of antibody binding to surface-immobilized antigen", J. Immunol. Methods, 115, pp.71~78 (1988)[DOI]